ResultsIQ

ResultsIQ › Latest results › Relaxo Footwears Limited

Relaxo Footwears Limited Q2 FY27 results deck summary

NSE: RELAXO · BSE: 530517

Results deck of 13 Nov 2026, summarised by AI from the filing.

Relaxo's Q2 FY27 revenue from operations rose 11.63% to ₹701.62 cr, but EBITDA margin fell to 12.15% from 15.35% in Q1FY27.

Key takeaways

  1. No guidance The presentation gives no forward revenue, margin or capex guidance for FY27 or beyond.
  2. Margin dip Q2 FY27 EBITDA margin fell to 12.15% from 15.35% in Q1FY27, a 320 bps decline.
  3. Capacity cut Production capacity was recalibrated to 9.1 lakh pairs per day from 10.5 lakh pairs per day during the RFL – I & II upgrade.

Original filing on BSE

Relaxo Footwears Limited Q2 FY27 results

As filed: Revenue ₹702 cr (+12% year on year), EBITDA ₹85.3 cr (+5% year on year), PAT ₹37.0 cr (+3% year on year), EBITDA margin 12.2% (−73 bps).

The Q2 FY27 score, against the company's own trend, is for premium members.

Earlier results and the share price after them

  • Q1 FY27: Revenue ₹705 cr (+8% year on year), EBITDA ₹108 cr (+8% year on year), PAT ₹54.9 cr (+12% year on year), EBITDA margin 15.4% (+6 bps). Score 70 of 100, Above trend. Revenue and EBITDA growth were well above the company's own trend; profit growth was above it. EBITDA margin was flat year on year. Revenue fell 6% from last quarter. Share price after the results: −22.5% in 29 days (Nifty 500: −3.3%).
  • Q4 FY26: Revenue ₹751 cr (+8% year on year), EBITDA ₹124 cr (+12% year on year), PAT ₹67.7 cr (+21% year on year), EBITDA margin 16.5% (+54 bps). Score 82 of 100, Above trend. Revenue, EBITDA and profit growth were well above the company's own trend. EBITDA margin rose 54 bps year on year. Share price after the results: +36.9% in 28 days (Nifty 500: +0.6%).
  • Q3 FY26: Revenue ₹668 cr (0% year on year), EBITDA ₹69.4 cr (−16% year on year), PAT ₹26.5 cr (−20% year on year), EBITDA margin 10.4% (−206 bps). Score 21 of 100, Below trend. Revenue growth was in line with the company's own trend; EBITDA and profit growth were well below it. EBITDA margin fell 206 bps year on year. Other income 31% of PBT. Profit fell 26% from last quarter. Share price after the results: −8.0% in 28 days (Nifty 500: +0.4%).
  • Q2 FY26: Revenue ₹629 cr (−7% year on year), EBITDA ₹81.0 cr (−8% year on year), PAT ₹36.0 cr (−3% year on year), EBITDA margin 12.9% (−8 bps). Score 33 of 100, Below trend. Revenue growth was well below the company's own trend; EBITDA growth was below it; profit growth was in line with it. EBITDA margin was flat year on year. Revenue fell 4% from last quarter. Share price after the results: −5.7% in 29 days (Nifty 500: −0.4%).
  • Q1 FY26: Revenue ₹654 cr (−13% year on year), EBITDA ₹100 cr (+1% year on year), PAT ₹49.0 cr (+11% year on year), EBITDA margin 15.3% (+206 bps). Score 45 of 100, In line with trend. Revenue growth was well below the company's own trend; EBITDA growth was in line with it; profit growth was above it. EBITDA margin rose 206 bps year on year. Revenue fell 6% from last quarter. Share price after the results: −1.1% in 30 days (Nifty 500: −2.5%).
  • Q4 FY25: Revenue ₹695 cr (−7% year on year), EBITDA ₹111 cr (−8% year on year), PAT ₹56.0 cr (−8% year on year), EBITDA margin 16.0% (−9 bps). Score 32 of 100, Below trend. Revenue growth was well below the company's own trend; EBITDA and profit growth were below it. EBITDA margin was flat year on year. Share price after the results: +6.5% in 30 days (Nifty 500: +3.7%).
  • Q3 FY25: Revenue ₹667 cr (−6% year on year), EBITDA ₹83.0 cr (−6% year on year), PAT ₹33.0 cr (−15% year on year), EBITDA margin 12.4% (+10 bps). Score 32 of 100, Below trend. Revenue growth was well below the company's own trend; EBITDA and profit growth were below it. EBITDA margin rose 10 bps year on year. Profit fell 11% from last quarter.

Past price moves after results do not indicate future moves. Not a recommendation.

Relaxo Footwears Limited earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.